Novartis AG (SWX:NOVNEE)

Market Cap	188.78B
Revenue (ttm)	43.89B
Net Income (ttm)	10.86B
Shares Out	n/a
EPS (ttm)	5.45
PE Ratio	17.39
Forward PE	14.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,381
Average Volume	346,061
Open	95.85
Previous Close	93.79
Day's Range	95.81 - 97.03
52-Week Range	81.55 - 102.82
Beta	0.49
RSI	61.77
Earnings Date	Jul 17, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: NOVNEE

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD